JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2002; 40:49-55
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blake, G. J.
Right arrow Articles by Kuntz, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blake, G. J.
Right arrow Articles by Kuntz, K. M.

Projected life-expectancy gains with statin therapy for individuals with elevated c-reactive protein levels

Gavin J. Blake, MB, MSc, MRCP*, Paul M. Ridker, MD, MPH*,* and Karen M. Kuntz, ScD{dagger},*

* Center for Cardiovascular Disease Prevention, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA;
{dagger} Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA



View larger version (13K):

[in a new window]
 
Figure 1 Gains in life expectancy among men (A) and women (B) in the low-density lipoprotein (LDL)/high C-reactive protein (CRP) group, according to the rate of myocardial infarction (MI) and efficacy of statin therapy for the prevention of MI in the low LDL/high CRP group. Line with triangles = 60% efficacy; line with circles = 45% efficacy; line with squares = 30% efficacy. AFCAPS/TexCAPS = Air Force/Texas Coronary Atherosclerosis Prevention Study; WOSCOPS = West of Scotland Coronary Prevention Study.

 


View larger version (11K):

[in a new window]
 
Figure 2 Results of sensitivity analysis. Each bar indicates the effect on estimated gains in life expectancy associated with statin therapy in 58-year-old men and women in the low-density lipoprotein (LDL)/high C-reactive protein (CRP) group, when a range of different values (shown in parentheses) is used for the indicated variables. The results for men are shown by solid bars and the results for women by open bars. MI = myocardial infarction.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.